Search research articles
Contact Us
Filters
Showing results (91-100 of 225) with videos related to
Page
of 23
Sort By:
Radiology
|
February 13, 2001
Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress
S E Langerak, P Kunz, H W Vliegen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group
M P de Maat, J J Kastelein, J W Jukema, et al.
The International Journal of Cardiovascular Imaging
|
December 21, 2010
Functional analysis by 64-slice CT scanning: prediction of left ventricular dysfunction together with reduction in radiation exposure?
E E van der Wall, F R de Graaf, J E van Velzen, et al.
Atherosclerosis
|
February 21, 2012
Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice
M M Ewing, J C Karper, M L Sampietro, et al.
Circulation
|
November 1, 1995
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
R P Byington, J W Jukema, J T Salonen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease
J W Jukema, M Lenselink, G J de Grooth, et al.
Annals of Human Genetics
|
April 5, 2003
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus
M W T Tanck, A H E M Klerkx, J W Jukema, et al.
The American Journal of Cardiology
|
October 6, 2000
Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
H J Mulder, E T Bal, J W Jukema, et al.
The International Journal of Cardiovascular Imaging
|
July 13, 2010
IVUS detects more coronary calcifications than MSCT; matter of both resolution and cross-sectional assessment?
E E van der Wall, F R de Graaf, J E van Velzen, et al.
European Journal of Clinical Investigation
|
February 27, 2004
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
A H E M Klerkx, G J de Grooth, A H Zwinderman, et al.
Page
of 23
Search research articles
Search
Showing results (91-100 of 225) with videos related to
Sort By:
Page
of 23
Radiology
|
February 13, 2001
Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress
S E Langerak, P Kunz, H W Vliegen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
-455G/A polymorphism of the beta-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fibrinogen. REGRESS group
M P de Maat, J J Kastelein, J W Jukema, et al.
The International Journal of Cardiovascular Imaging
|
December 21, 2010
Functional analysis by 64-slice CT scanning: prediction of left ventricular dysfunction together with reduction in radiation exposure?
E E van der Wall, F R de Graaf, J E van Velzen, et al.
Atherosclerosis
|
February 21, 2012
Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice
M M Ewing, J C Karper, M L Sampietro, et al.
Circulation
|
November 1, 1995
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
R P Byington, J W Jukema, J T Salonen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Enhancing reverse cholesterol transport/raising HDL cholesterol: new options for prevention and treatment of cardiovascular disease
J W Jukema, M Lenselink, G J de Grooth, et al.
Annals of Human Genetics
|
April 5, 2003
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus
M W T Tanck, A H E M Klerkx, J W Jukema, et al.
The American Journal of Cardiology
|
October 6, 2000
Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
H J Mulder, E T Bal, J W Jukema, et al.
The International Journal of Cardiovascular Imaging
|
July 13, 2010
IVUS detects more coronary calcifications than MSCT; matter of both resolution and cross-sectional assessment?
E E van der Wall, F R de Graaf, J E van Velzen, et al.
European Journal of Clinical Investigation
|
February 27, 2004
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
A H E M Klerkx, G J de Grooth, A H Zwinderman, et al.
Page
of 23